Her Labs Were "Optimized." Her Life Was Not.

Her labs were "optimized."

Her life was not.

And nobody could explain why.

She was in her early forties. She had spent nearly two years — and roughly fifteen thousand dollars — inside one of the well-known precision medicine platforms that now dominate the modern longevity space. She had done the comprehensive biomarker panels, the hormone optimization protocols, the supplements, the recurring telehealth visits.

Her testosterone levels sat near the top of the platform's recommended range. Despite this, the platform kept increasing her testosterone, on the logic that her symptoms must mean her levels were still too low.

Meanwhile, she was sleeping poorly, emotionally volatile, exhausted in the second half of her cycle, and increasingly disconnected from herself.

Nobody had asked where she was in her menstrual cycle when the labs were drawn. Nobody had interpreted her progesterone in a cycle-aware way. Nobody had explored the relationship between her stress physiology, sleep disruption, perimenopausal transition, and hormonal symptoms. The framework she had paid into did not have a place for the questions her body was actually asking.

She is not unusual.

I have now seen many women with versions of this same story — women whose biomarkers looked "optimal" while their physiology was quietly deteriorating underneath the interpretation.

I want to explain why this happens.

The Default Body in Medicine

Most modern medical research was built using male physiology as the reference model.

This is not ideological. It is historical fact.

Until the 1990s, women were significantly underrepresented in clinical research, particularly in early-stage drug trials. Much of the laboratory data, dosing guidance, symptom recognition, and disease modeling still embedded in modern medicine today emerged from male populations first, and female physiology was layered in later as a modification of the original framework.

The consequences of this are still unfolding.

We now know women present differently, metabolize differently, transition hormonally differently, and respond differently to stress and disease than men. Cardiovascular disease frequently presents differently in women. Autoimmune disease behaves differently in women. Drug metabolism differs. Hormonal transitions alter physiology in ways standard reference ranges often fail to capture.

We have also learned something even more important:

Female physiology is rhythmic physiology.

A 2016 study published in Scientific Reports demonstrated that serum biomarkers vary significantly not only between men and women, but across different hormonal states within women themselves — including menstrual cycle phase, contraceptive use, and menopausal status. Researchers found that biomarker studies that failed to account for these variables produced false interpretations in up to 40 percent of cases.

In plain English: if you draw female hormones without understanding where a woman is in her cycle, there is a meaningful possibility you are misinterpreting the data entirely.

And yet this happens constantly.

This is the hidden substrate underneath much of modern women's healthcare — including large portions of the precision medicine movement itself.

What Precision Medicine Got Right

To be fair, the precision medicine movement emerged in response to real failures within conventional healthcare.

And in many ways, it was right.

The willingness to look beyond disease management and toward prevention was important. The recognition that lifestyle, metabolism, inflammation, sleep, and hormones matter was important. The willingness to use broader biomarker panels than conventional primary care often orders was an improvement.

Most importantly, these platforms recognized something patients already knew:

People do not want to wait until they are sick enough to qualify as diseased before anyone pays attention.

That mattered.

But many precision medicine systems carried forward an assumption they never fully examined: that female physiology could be interpreted using largely the same architecture developed for men.

This is where the framework begins to fail women.

The Problem With Static Measurement

Most precision medicine platforms rely heavily on snapshot biomarker interpretation.

For men, this is often reasonably effective. Male testosterone follows a relatively stable daily rhythm. Single measurements are imperfect, but clinically useful.

Female reproductive hormones do not behave this way.

Estradiol can change dramatically over the course of a single week. Progesterone is low for the first half of the cycle, then rises sharply during the luteal phase. Perimenopause introduces entirely new patterns — fluctuation, irregularity, surges, instability — often years before a woman officially reaches menopause.

A hormone panel drawn on the wrong day may not clarify physiology.

It may distort it.

Female hormones are not single values. They are patterns.

Good women's medicine requires understanding rhythm, timing, transition, and context — not simply optimizing isolated numbers against generalized reference ranges.

Treating female physiology statically is one of the most common and least recognized errors in modern medicine.

The Testosterone Problem

Many modern optimization platforms were built around male hormonal decline.

Historically, the foundational clinical question was straightforward: what happens when testosterone declines in aging men, and how do we restore it?

The entire architecture of many longevity platforms evolved from this premise.

Women were later integrated into the system by adding estrogen, progesterone, DHEA, and female-focused protocols onto an already male-centered framework.

But female hormonal physiology is not a male system with additional hormones attached to it.

It is its own regulatory system entirely.

The ovarian cycle involves dynamic signaling between the hypothalamus, pituitary, ovaries, adrenal system, thyroid physiology, metabolic status, stress physiology, sleep architecture, and environmental inputs. Perimenopause introduces a decade-long transition that often cannot be captured by static optimization targets at all.

A woman is not "low testosterone with extra complexity."

She is operating within a different physiologic architecture.

And medicine that fails to recognize this will continue to produce women whose labs improve while their lives worsen.

Women Are Contextual Physiology

This is the part medicine still struggles to quantify.

Women's physiology is deeply contextual.

Sleep changes hormones.

Stress changes ovulation.

Relationships alter cortisol signaling.

Undernourishment changes thyroid function.

Trauma changes autonomic tone.

Perimenopause changes all of it again.

These systems are not separate.

They are interacting continuously.

I have yet to meet a woman whose hormones exist separately from her life.

A woman whose nervous system has been running on high alert for fifteen years may not respond predictably to hormone replacement alone. A woman experiencing chronic sleep disruption, blood sugar instability, emotional overload, environmental toxin exposure, and declining progesterone signaling is not experiencing five separate problems.

She is experiencing one interconnected physiology expressing distress through multiple systems simultaneously.

This cannot be fully understood through isolated biomarkers interpreted by rotating clinicians working from standardized protocols.

And this is where continuity of care becomes essential.

The Relationship Matters

In women's medicine, continuity is not a luxury.

It is part of the treatment itself.

The physician who knows your cycle history, your pregnancies, your sleep patterns, your stress physiology, your response to prior interventions, your emotional landscape, your pace of transition into menopause — that longitudinal understanding changes the quality of interpretation entirely.

Women's medicine is pattern recognition across time.

Not isolated snapshots.

Not quarterly lab optimization.

Not algorithmic adjustments detached from lived physiology.

The longer I practice medicine, the less interested I become in chasing isolated numbers detached from the human being sitting in front of me.

The relationship itself becomes clinically meaningful because context changes interpretation.

The same progesterone level can mean entirely different things in two different women living two different lives.

Good medicine recognizes this.

What Good Women's Medicine Actually Requires

Good women's medicine requires cycle-aware testing when women are still menstruating.

It requires lifespan-aware interpretation rather than one generic "normal range" applied across decades of radically different physiology.

It requires understanding reproductive years, postpartum transitions, perimenopause, menopause, hormonal contraception, hysterectomy status, stress physiology, metabolic health, and nervous system regulation as interacting variables rather than separate specialties.

It also requires discernment.

There is absolutely a place for advanced diagnostics: genomics, microbiome analysis, micronutrient testing, environmental toxin assessment, advanced cardiovascular risk markers, comprehensive hormone analysis.

Used thoughtfully, these tools can be extraordinarily helpful.

Used indiscriminately, they become expensive medical theater.

The goal is not more testing.

The goal is more accurate interpretation.

What We're Trying to Build

At Big Island WellCare, I built the kind of practice I wished more women had access to.

A practice with continuity. With time. With context. With thoughtful interpretation. With medicine that respects female physiology as its own system rather than a modified version of male biology.

When we test hormones in women who are still cycling, we test them in a cycle-aware way. When we interpret labs, we interpret them against the patient's actual life stage — reproductive, perimenopausal, postmenopausal, postpartum — not against a generic adult range. When we approach perimenopause, we treat it as the multi-year physiologic transition it actually is, not as a vague stretch of "just aging" to be ridden out.

We use advanced testing when it is clinically useful, not as a default product. We use medications when they help. We use lifestyle interventions when they matter. We integrate hormone therapy into the broader physiologic picture rather than treating hormones in isolation.

Most importantly, we take women seriously when they say something feels wrong — even when the labs appear "normal."

Because a reference range does not define health.

And optimized biomarkers do not always reflect physiologic well-being.

If You Are Reading This

If you are considering a precision medicine platform, ask better questions.

How do they interpret hormones in cycling women?

How do they approach perimenopause specifically?

Will you see the same clinician consistently?

How much of their framework was originally designed around male physiology?

How do they account for nervous system health, sleep, stress, and life-stage transitions?

The answers matter more than the marketing.

And if your labs look "optimized" while your body continues telling you otherwise, trust that signal.

Women are not modified men. They are women — and their physiology demands its own medicine.

Medicine that ignores this will continue missing women — even when the numbers look perfect.

—
Dr. Kristy King, MD
Board-Certified Family Physician
Big Island WellCare · Waimea, Hawai'i